Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer
I would not wait six months for more data. A potentially fatal signal affecting a drug used by millions requires immediate safety assessment, prompt engagement with regulators, and a plan to inform patients and clinicians.Read the full answer